i
Important informations

LDI

The Lady Davis Institute for Medical Research

The research arm of the Jewish General Hospital

The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.

We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.

The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Latest News

Tweets

Emeritus

Adjuvant therapy in breast cancer, Breast cancer, Breast cancer prevention, Breast cancer surgery, Clinical trials, Early-stage breast cancer, Surgical oncology

Clinical Epidemiology

Appropriate medication use, Clinical Trials in the Primary Care Setting, Delirium, Dementia, Long-term care, Pharmacoepidemiology

Molecular & Regenerative Medicine

Atherosclerosis, Biomechanics, Cardiovascular diseases, Immunology, Inflammation

Psychosocial aspects of disease

Anxiety, Coping, Depression, Emotion regulation, Perfectionism, Self-criticism, Stress

Cancer

Brain tumor microenvironment, Drug design, Glioma progression, Organ-selective metastasis

Cancer

Atypical ductal hyperplasia, Atypical lobular hyperplasia, BRCA 1/2, Breast cancer susceptibility genes, Chemoprevention, Endocrine prevention, Lobular carcinoma in situ, Mainstream genetic testing, Prophylactic mastectomy, Risk reducing mastectomy

Clinical Epidemiology

Artificial Intelligence, Electronic Data, Emergency Department Operations, Emergency Department Triage, Machine learning

Psychosocial aspects of disease

Contemplative Practice, Meditation, Neurophenomenology, Placebos, Prayer, Psychedelics

National Collaborations and Partnerships